San Francisco, CA, United States of America

Hosea Nelson

USPTO Granted Patents = 4 

Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Hosea Nelson: Innovator in Drug Discovery Technologies

Introduction

Hosea Nelson is a prominent inventor based in San Francisco, CA, known for his contributions to drug discovery technologies. With a total of 4 patents, he has made significant advancements in the field of structural characterization of compounds.

Latest Patents

His latest patents include a high throughput drug discovery platform utilizing transmission electron microscopy (TEM). This patent focuses on methods for obtaining electron diffraction data from microcrystalline samples. Another notable patent involves systems and methods for structurally characterizing compounds, which provide innovative techniques for collecting electron diffraction patterns from nanocrystals. These methods enable the creation of three-dimensional structural models of compounds, identification of compounds, and determination of polymorphic forms. Additionally, the patent outlines systems for characterizing compounds from samples, incorporating modules for high-performance liquid chromatography, dispensing, and electron microscopy.

Career Highlights

Hosea has worked with esteemed institutions such as the California Institute of Technology and the University of California. His work at these institutions has contributed to the advancement of research in drug discovery and structural biology.

Collaborations

Throughout his career, Hosea has collaborated with notable colleagues, including Brian M Stoltz and Kei Murakami. These collaborations have further enriched his research and innovation in the field.

Conclusion

Hosea Nelson's work in drug discovery technologies exemplifies the impact of innovative thinking in scientific research. His patents and collaborations highlight his commitment to advancing the understanding of compound characterization and drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…